APOC3 Variants and Their Impact on Liver Fat and Insulin Resistance
Author Information
Author(s): Julia Kozlitina, Eric Boerwinkle, Jonathan C. Cohen, Helen H. Hobbs
Primary Institution: University of Texas Southwestern Medical Center
Hypothesis
Do APOC3 variants influence hepatic triglyceride content and insulin resistance?
Conclusion
The study found no causal relationship between APOC3 variants and hepatic triglyceride content or insulin resistance.
Supporting Evidence
- APOC3 variants were not associated with insulin resistance in the Dallas Heart Study.
- Neither APOC3 variant showed consistent relationships with plasma triglyceride concentrations.
- The study included a diverse population to assess the impact of genetic variants.
Takeaway
This study looked at how certain gene changes might affect fat in the liver and how our bodies respond to insulin, but it found that these gene changes don't really make a difference.
Methodology
The study genotyped two APOC3 variants in a multiethnic population and tested their association with hepatic triglyceride content and insulin resistance.
Limitations
The study did not find significant associations in lean individuals or when controlling for various factors.
Participant Demographics
Participants included 1228 African Americans, European Americans, and Hispanics.
Statistical Information
P-Value
0.04
Statistical Significance
p=0.04
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website